XNK Therapeutics continues platform development work with AdBIOPRO…
HUDDINGS, Sweden, November 21, 2022 /PRNewswire/ — XNK Therapeutics AB (“XNK”) announced today that it will continue its partnership with Karolinska Cell Therapy Center’s manufacturing